Podcast #33: Foreign-Sponsored Clinical Trials Under China's Human Genetic Resources Regime – Tina Wu, Haiwen & Partners

May 14, 2021
| By Vincent Chow
China's HGR regime still delays foreign-sponsored clinical research despite recent streamlining of review process

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

To continue reading,
become a free ALM digital reader

Benefits include:

  • Access to China Law & Practice original news online
  • China Law & Practice newsletters
  • Access to other ALM subscription sites with 1 free article*every 30 days
  • Exclusive discounts on events and publications produced by ALM

*May exclude premium content